InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,648.40
(
1.01%
)
US TECH 100
19,050.40
(
1.19%
)
Dow Jones
41,563.08
(
0.55%
)
Brent Oil
76.52
(
-0.62%
)
Bitcoin
57,947.33
(
-1.75%
)
Post# of 20775
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

CDirt

Send PM Follow Ignore
Followers 7
Posts 607
Boards Moderated 0
Alias Born 10/31/2008

CDirt

Re: None

Tuesday, 04/27/2010 2:53:14 PM

Tuesday, April 27, 2010 2:53:14 PM

Post# of 20775
ILNS .165 x.19

From recent news, GLOBE NEWSWIRE
Intellect Neurosciences, Inc. (OTCBB:ILNS), a biopharmaceutical company focused on development of disease-modifying therapeutic agents for Alzheimer's disease ("AD"), announced today it has completed a restructuring of its balance sheet. The result is the extinguishment of approximately $24 million of aggregate face amount plus accrued interest of debt and preferred stock through the issuance of common stock. Further, several of Intellect's significant shareholders
have collectively provided sufficient funds to support the Company's core operations for the next 12 months.

http://ih.advfn.com/p.php?pid=nmona&cb=1272394205&article=42526451&symbol=NB^ILNS


Link to chart http://investorshub.advfn.com/boards/read_msg.aspx?message_id=49338523


Captain Dirt to you.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up